Project Grant R01EY036506
Award Date 7/1/26
Completion Date 12/31/30
Dollars Obligated $747K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Ohio, USA
Similar Awards
- Federal Grant Award Summary The National Eye Institute (NEI) awarded The Aird $610,000 under the Vision Research program (CFDA 93.867) for a Project Grant commencing September 1, 2025, and concluding August 31, 2026. This award funds the development and commercialization of an adaptive optics optical coherence tomography (AO-OCT) system designed for high-resolution, wide-field retinal imaging in small animal models, particularly mice. The primary deliverable is a portable AO-OCT imaging system...
- Federal Project Grant Award Summary Kineolabs, Inc. received a $300,001 Project Grant from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) to develop a portable, low-cost line-scan swept-source optical coherence tomography imaging system (LS-SS-OCT). The system is designed for early detection and monitoring of age-related macular degeneration (AMD), diabetic retinopathy, and other eye diseases. The one-year project, which commenced July 1, 2025 and concludes June...
- Federal Project Grant Award Summary Award Overview The National Eye Institute (NEI) within the National Institutes of Health awarded a $413,478 Project Grant (CFDA 93.867 – Vision Research) to The Ohio State University, with an award date of September 22, 2025, and ultimate completion date of August 31, 2030. The research addresses inherited retinal disease (IRD), a molecularly heterogeneous group of chronic blinding conditions affecting 5.5 million people worldwide across mutations in over...
- Federal Project Grant Award Summary Eye C Better Corp received a $315,825 Project Grant from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867), effective September 1, 2025 through August 31, 2026. The award funds development of a novel, non-invasive intraocular pressure (IOP) measurement technology called Photonic IOP Biomonitoring (PIB) designed to address glaucoma management challenges. Glaucoma affects over 5 million Americans and costs the U.S. economy...
- Federal Project Grant Award Summary Oregon Health & Science University received a $1.73 million Project Grant award from the National Eye Institute (CFDA 93.867, Vision Research program) effective September 1, 2025 through April 30, 2030 to develop innovative ophthalmic imaging technologies and functional biomarkers for assessing photoreceptor health and visual function. The multidisciplinary research program aims to create next-generation Optical Coherence Tomography (OCT) technologies,...
- Summary of Federal Grant Award The National Eye Institute (NEI) awarded the University of Pittsburgh a $679,650 Project Grant under the Vision Research program (CFDA 93.867) effective June 1, 2026, through May 31, 2030. The award funds research to develop and validate adaptive optics ophthalmoscopy (AOO) as a non-invasive, label-free imaging tool for real-time assessment of immune responses in posterior uveitis, an inflammatory eye condition responsible for up to 10% of blindness in the United...
- Federal Project Grant Award Summary The National Eye Institute (NEI), under its Vision Research program (CFDA 93.867), awarded The Ohio State University $433,125 on August 1, 2025, to investigate tissue factor (TF) as a potential biomarker and therapeutic target for corneal neovascularization (CNV). This two-year project, concluding July 31, 2027, addresses a significant unmet medical need, as CNV—the pathological growth of blood vessels in the cornea—is a common sequela of corneal diseases...
- Federal Grant Award Summary The National Eye Institute (NEI) awarded a $421,136 Project Grant to the University of Maryland, College Park, effective August 1, 2025, through July 31, 2027, under the Vision Research program (CFDA 93.867). This award supports research into advanced wavefront shaping techniques designed to enable high-resolution fundus imaging in patients with ocular opacities—conditions affecting the cornea and lens that currently prevent effective posterior segment eye...
- Summary The National Eye Institute (NEI), under its Vision Research program (CFDA 93.867), awarded $417,162 to the University of Houston System for a two-year project (July 1, 2025 – June 30, 2027) investigating the birefringence properties of the lamina cribrosa and posterior eye structures as they relate to glaucoma detection and diagnosis. The project addresses a critical clinical need by developing advanced optical imaging methodologies to detect early structural and stress-related changes...
- Federal Project Grant Award Summary The National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), awarded $1,141,121 to Cleveland Clinic Lerner College of Medicine of Case Western Reserve University beginning September 1, 2025, with completion targeted for April 30, 2030. The project investigates the role of melanopsin in photoreceptor outer segment renewal, a fundamental cellular maintenance process essential to lifelong vision health. The research will examine how...